Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 4519-17-9 | MDL No. : | MFCD07778038 |
Formula : | C14H22Si2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VLNRSEGRGSDKLS-UHFFFAOYSA-N |
M.W : | 246.50 | Pubchem ID : | 320767 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 0.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 81.07 |
TPSA : | 0.0 Ų |
GI absorption : | Low |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -3.49 cm/s |
Log Po/w (iLOGP) : | 3.71 |
Log Po/w (XLOGP3) : | 6.07 |
Log Po/w (WLOGP) : | 2.97 |
Log Po/w (MLOGP) : | 4.49 |
Log Po/w (SILICOS-IT) : | 2.0 |
Consensus Log Po/w : | 3.85 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -5.21 |
Solubility : | 0.00153 mg/ml ; 0.00000622 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -5.85 |
Solubility : | 0.000348 mg/ml ; 0.00000141 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -5.05 |
Solubility : | 0.00219 mg/ml ; 0.00000887 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 3.68 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | Stage #1: With magnesium In tetrahydrofuran at 40℃; Stage #2: at 20 - 40℃; |
General procedure: Magnesium 1.28 g (52.5 mmol) was added to a dried flask. Then a solution of 6.59 g (25 mmol) 3,6-(dibromo)benzocyclobutene in 20 mL freshly distilled THF was added dropwise over a period of 2 h. The reaction mixture was heated to 40°C and stirred continuously for 2 h. After cooled to room temperature, a solution of 6.65 g (55 mmol) of (vinyldimethylchloro)silane in 15 mL freshly distilled THF was added into the reaction mixture over a period of 1 h at ambient temperature. The reaction mixture was then heated to 40°C, and stirred for 2 h. Then the mixture was allowed to stand overnight and was poured into distilled water. The aqueous phase was extracted with petroleum ether (30 mL×3). The organic layers were combined and dried over anhydrous sodium sulfate. After removal of the solvents under reduced pressure, the residue was purified by chromatography (petroleum ether) to give 2 of 5.57 g (82percent yield). |
[ 13183-70-5 ]
1,4-Bis(trimethylsilyl)benzene
Similarity: 0.93
[ 185626-73-7 ]
(3-Bromophenyl)triphenylsilane
Similarity: 0.70